Mayo Clinic Q and A: Hair transplant treatment for hair loss
DEAR MAYO CLINIC: What is involved in a hair transplant, and how long does it last? How does this differ from hair plugs? I?m only 34 but have lost a lot of hair already and have tried hair-growth shampoo without much luck. ANSWER: A hair transplant is a form of skin graft that rearranges the [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - October 27, 2017 Category: Databases & Libraries Source Type: news
RenovaCare raises $2m on path to improve burn, wound care with its “ SkinGun ”
RenovaCare said this week it raised $2.3 million in a new direct offering to support its “SkinGun,” which CEO Thomas Bold thinks could be a significant boon to the burn and wound care industry.
This summer, CEO Bold spoke to MassDevice.com about the company’s SkinGun and CellMist technologies and what he thinks they can do to improve outcomes and reduce pain compared to current wound care treatments.
The company’s SkinGun uses a sample of stem cells collected from a patient’s healthy skin, which are isolated and placed into a water-based solution in a syringe, which is then attached to the device....
Source: Mass Device - October 20, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Research & Development Wound Care RenovaCare Source Type: news
The Sweet Way to Heal Your Wounds
We enjoy outdoor activities.
My family will be coming over this year and I will fire up the grill for a delicious BBQ grass-fed beef. We’ll play games like badminton and horseshoes.
Now while these games can be fun, they can lead to cuts and bruises.
I want to aim you with an unconventional solution for those wounds.
For years now, sugar’s been a dirty word. It’s been blamed for everything from obesity, heart disease and diabetes to tooth decay and acne. But there’s something they don’t know. Sugar’s better for you than all those artificial sweeteners and substitutes out there toda...
Source: Al Sears, MD Natural Remedies - October 5, 2017 Category: Complementary Medicine Authors: Al Sears Tags: Anti-Aging Source Type: news
US Dept of HHS pulls the trigger on $24m contract option with Avita Medical
Avita Medical (ASX:AVH) said today it is executing a $24.3 million expanded contract option with the US Department of Health and Human Services to support development and procurement of its ReCell devices.
The option is related to an original contract between Avita Medical and the Biomedical Advanced Research and Development Authority division of the HHS, and will extend Avita’s Project Bioshield contract through Sept. 2022, the Cambridge, U.K.-based company said.
The company originally won the BARDA contract in Sept. 2015, providing an initial $16.9 million to support eventual FDA premarket approval for its ReCell ...
Source: Mass Device - September 21, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Regenerative Medicine avitamedical Source Type: news
Bolstering Skin Grafts With a Surgical Scrub Brush Bolstering Skin Grafts With a Surgical Scrub Brush
How does the dry, sterile surgical scrub brush compare with other options for the bolstering of skin grafts?ePlasty, Open Access Journal of Plastic Surgery (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 19, 2017 Category: Consumer Health News Tags: Plastic Surgery & Aesthetic Medicine Journal Article Source Type: news
A natural ligand for the orphan receptor GPR15 modulates lymphocyte recruitment to epithelia
We describe the purification from porcine colonic tissue extracts of an agonistic ligand for GPR15 and its functional characterization. In humans, this ligand, which we named GPR15L, is encoded by the gene C10ORF99 and has some features similar to the CC family of chemokines. GPR15L was found in some human and mouse epithelia exposed to the environment, such as the colon and skin. In humans, GPR15L was also abundant in the cervix. In skin, GPR15L was readily detected after immunologic challenge and in human disease, for example, in psoriatic lesions. Allotransplantation of skin from Gpr15l-deficient mice onto wild-type mic...
Source: Signal Transduction Knowledge Environment - September 12, 2017 Category: Science Authors: Suply, T., Hannedouche, S., Carte, N., Li, J., Grosshans, B., Schaefer, M., Raad, L., Beck, V., Vidal, S., Hiou-Feige, A., Beluch, N., Barbieri, S., Wirsching, J., Lageyre, N., Hillger, F., Debon, C., Dawson, J., Smith, P., Lannoy, V., Detheux, M., Bitsch Tags: STKE Research Articles Source Type: news
Gene therapy trial offers hope for Harry
Harry and his father at Dana/Farber-Boston Children’s
In their Brookline home-away-from-home, 2-year-old Duy Anh “Harry” Le plays with blocks and pop-up toys on the floor with his mother, Thao Nguyen. He is lively and happy, and his skin is clear. He looks almost nothing like the sickly baby covered in eczema who arrived in Boston from his native Vietnam in November of 2016 to participate in a gene therapy clinical trial for Wiskott-Aldrich syndrome.
Children with the potentially life-threatening, inherited immune system deficiency have difficulty producing platelets, the blood component that fosters clotting, wh...
Source: Thrive, Children's Hospital Boston - August 23, 2017 Category: Pediatrics Authors: Irene Sege Tags: Diseases & Conditions Our Patients’ Stories Dana-Farber/Boston Children's Cancer and Blood Disorders Center Dr. Sung-Yun Pai gene therapy Wiskott-Aldrich syndrome Source Type: news
Pain and itch outcome trajectories differ among European American and African American survivors of major thermal burn injury
Over half of individuals experiencing major thermal burn injury (MThBI) receive an autologous skin graft (autograft), in which skin is removed from a healthy " donor " site and transplanted to the burn site. Persistent pain/itch at the graft site are major causes of suffering and disability in MThBI survivors. African Americans have a higher risk of MThBI, and in other clinical settings African Americans experience a greater burden of pain and itch relative to European Americans. However, to our knowledge, ethnic differences in skin graft site pain/itch outcomes after MThBI have not been assessed. We evaluated skin graft s...
Source: Current Awareness Service for Health (CASH) - August 14, 2017 Category: Consumer Health News Source Type: news
Early ambulation after-grafting of lower extremity burns
Early ambulation of lower extremity burns that undergo a skin graft may help to avoid some of the complications associated with immobilization. Despite recent evidence supporting early ambulation, post-operative immobilization following lower extremity skin grafting is still a common practice. The purpose of this single centre, observational study was to retrospectively assess the outcomes of lower extremity skin graft cases dressed with a multi-layer compression bandage who were ambulated in the immediate post-operative period (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - August 11, 2017 Category: Consumer Health News Source Type: news
Skin Graft-based Gene Therapy Treats Diabetes in Mice
A small patch of engineered cells makes an enzyme that stimulates insulin release. (Source: The Scientist)
Source: The Scientist - August 4, 2017 Category: Science Tags: Daily News,The Scientist Source Type: news
Skin transplants could treat type 2 diabetes and obesity
Scientists have described a novel approach using CRISPR and skin grafts to boost insulin levels and reduce weight in mice. The study was published inCell Stem Cell.Science Daily (Source: Society for Endocrinology)
Source: Society for Endocrinology - August 4, 2017 Category: Endocrinology Source Type: news
Medical News Today: Genetically engineered skin grafts may help with diabetes, obesity
Genetically engineered skin grafts are effective on wild type mice with healthy immune systems, but diet-induced diabetes and obesity, study finds. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - August 3, 2017 Category: Consumer Health News Tags: Genetics Source Type: news
Engineered Skin Cells Control Type 2 Diabetes in Mice
'Therapeutic skin grafts' might someday treat multiple diseases, researchers saySource: HealthDay Related MedlinePlus Pages: Diabetes Type 2, Genes and Gene Therapy, Stem Cells (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - August 3, 2017 Category: Consumer Health News Source Type: news
Avita to seek PMA for ReCell burn indication, considers making US operations hub
Avita Medical (ASX:AVH) today released an update on its future plans, saying it it intends to submit an application to the FDA for Premarket Approval for its ReCell device for use in patients with severe burns and that it’s considering making the US its center of operations.
The ReCell device is designed to use the patient’s own skin cells to treat a variety of skin issues, including burns, reconstructive and cosmetic procedures, the company said.
Avita said that the decision to pursue FDA approval for the device under the indication came after it completed a US pivotal trial of the device for treating burns, whic...
Source: Mass Device - July 13, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Food & Drug Administration (FDA) Regenerative Medicine Regulatory/Compliance Avita Medical Ltd. Source Type: news
MassDevice.com +5 | The top 5 medtech stories for July 3, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. BD extends Bard note exchange offering again
Becton Dickinson said today is once again extending its exchange offering for up to $1.1 billion in outstanding C. R. Bard notes from July 3 to August 1.
The company is offering exch...
Source: Mass Device - July 3, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news
